| My Florida Community Health Center Llc | |
|
10887 Nw 17th St Unit 203 Miami FL 33172-2046 | |
| (786) 233-6218 | |
| Not Available |
| Full Name | My Florida Community Health Center Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 10887 Nw 17th St Unit 203, Miami, Florida |
| Authorized Official Name and Position | Lisandra Valdivia (PRESIDENT) |
| Authorized Official Contact | 7862336218 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| My Florida Community Health Center Llc 10887 Nw 17th St Unit 203 Miami FL 33172-2046 Ph: () - | My Florida Community Health Center Llc 10887 Nw 17th St Unit 203 Miami FL 33172-2046 Ph: (786) 233-6218 |
| NPI Number | 1043801970 |
|---|---|
| Provider Enumeration Date | 02/02/2021 |
| Last Update Date | 05/11/2023 |
| Certification Date | 05/11/2023 |
| Medicare PECOS PAC ID | 8426447566 |
|---|---|
| Medicare Enrollment ID | O20211111001480 |
News Archive
Play is critical to children's development, including children with autism spectrum disorders (ASD). Kathy Ralabate Doody, assistant professor of exceptional education at SUNY Buffalo State, observed different play options to determine those most likely to appeal to children with ASD.The findings were published in the North American Journal of Medicine and Science.
In an article featured on the cover of the March issue of Nature Nanotechnology, Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston, presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective.
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemoglobinuria (PNH).
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
A recent scoping review, published online in the Journal of Aging and Environment, found that older adults with dementia or cognitive impairment who live in subsidized housing face complex challenges that, left unaddressed, threaten to exacerbate their health and ability to age in place.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043801970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Eduardo F Bolumen |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1174582639 PECOS PAC ID: 3173811239 Enrollment ID: I20161005003075 |
News Archive
Play is critical to children's development, including children with autism spectrum disorders (ASD). Kathy Ralabate Doody, assistant professor of exceptional education at SUNY Buffalo State, observed different play options to determine those most likely to appeal to children with ASD.The findings were published in the North American Journal of Medicine and Science.
In an article featured on the cover of the March issue of Nature Nanotechnology, Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston, presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective.
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemoglobinuria (PNH).
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
A recent scoping review, published online in the Journal of Aging and Environment, found that older adults with dementia or cognitive impairment who live in subsidized housing face complex challenges that, left unaddressed, threaten to exacerbate their health and ability to age in place.
› Verified 9 days ago
News Archive
Play is critical to children's development, including children with autism spectrum disorders (ASD). Kathy Ralabate Doody, assistant professor of exceptional education at SUNY Buffalo State, observed different play options to determine those most likely to appeal to children with ASD.The findings were published in the North American Journal of Medicine and Science.
In an article featured on the cover of the March issue of Nature Nanotechnology, Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston, presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective.
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemoglobinuria (PNH).
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
A recent scoping review, published online in the Journal of Aging and Environment, found that older adults with dementia or cognitive impairment who live in subsidized housing face complex challenges that, left unaddressed, threaten to exacerbate their health and ability to age in place.
› Verified 9 days ago
Future Care Solution Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3911 Sw 67th Ave, Miami, FL 33155 Phone: 305-740-6960 Fax: 305-740-6959 | |
Kids Behaviors Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14554 Sw 143rd Pl, Miami, FL 33186 Phone: 786-523-2414 | |
Deborah M. Thevenin, Ph.d., Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7685 Sw 104th St, Suite 100, Miami, FL 33156 Phone: 305-666-8000 Fax: 305-666-4311 | |
Miami-dade County Community Action And Human Services Department Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 Nw 79th St, Miami, FL 33150 Phone: 305-751-4342 Fax: 305-759-2763 | |
Luzmila Victorero Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 Sw 77th Ave, Miami, FL 33144 Phone: 786-406-4933 | |
Adaga Therapy Group Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2926 Sw 145th Ave, Miami, FL 33175 Phone: 305-301-1856 | |
Advance Behavior Coalition Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14531 Sw 157th Ct, Miami, FL 33196 Phone: 305-733-9005 |